![PDF) Recent updates in cancer immunotherapy: A comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing PDF) Recent updates in cancer immunotherapy: A comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing](https://i1.rgstatic.net/publication/329847428_Recent_updates_in_cancer_immunotherapy_A_comprehensive_review_and_perspective_of_the_2018_China_Cancer_Immunotherapy_Workshop_in_Beijing/links/5c1d9966a6fdccfc705ffd62/largepreview.png)
PDF) Recent updates in cancer immunotherapy: A comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
![Molecules | Free Full-Text | Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights Molecules | Free Full-Text | Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights](https://pub.mdpi-res.com/molecules/molecules-27-02685/article_deploy/html/images/molecules-27-02685-g001.png?1650602382)
Molecules | Free Full-Text | Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights
![Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma | International Journal of Oral Science Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma | International Journal of Oral Science](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41368-021-00131-7/MediaObjects/41368_2021_131_Fig1_HTML.png)
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma | International Journal of Oral Science
![Clinical impact of tumour biology in the management of gastroesophageal cancer | Nature Reviews Clinical Oncology Clinical impact of tumour biology in the management of gastroesophageal cancer | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2016.15/MediaObjects/41571_2016_Article_BFnrclinonc201615_Fig1_HTML.jpg)
Clinical impact of tumour biology in the management of gastroesophageal cancer | Nature Reviews Clinical Oncology
![Complications following novel therapies for non‐small cell lung cancer - Skribek - 2022 - Journal of Internal Medicine - Wiley Online Library Complications following novel therapies for non‐small cell lung cancer - Skribek - 2022 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6f3026d8-4518-4e17-b6c0-e09ffc4ccb1b/joim13445-gra-0001-m.jpg)
Complications following novel therapies for non‐small cell lung cancer - Skribek - 2022 - Journal of Internal Medicine - Wiley Online Library
![IJMS | Free Full-Text | Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand? IJMS | Free Full-Text | Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?](https://www.mdpi.com/ijms/ijms-21-07935/article_deploy/html/images/ijms-21-07935-g001.png)
IJMS | Free Full-Text | Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?
![Biomedicines | Free Full-Text | Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management Biomedicines | Free Full-Text | Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management](https://www.mdpi.com/biomedicines/biomedicines-10-02047/article_deploy/html/images/biomedicines-10-02047-g001.png)
Biomedicines | Free Full-Text | Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management
![Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors | ACS Nano Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.8b00204/asset/images/large/nn-2018-002047_0009.jpeg)
Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors | ACS Nano
![IJMS | Free Full-Text | The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm IJMS | Free Full-Text | The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm](https://www.mdpi.com/ijms/ijms-22-00075/article_deploy/html/images/ijms-22-00075-g001.png)
IJMS | Free Full-Text | The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm
![Cancers | Free Full-Text | Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy Cancers | Free Full-Text | Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy](https://www.mdpi.com/cancers/cancers-14-01580/article_deploy/html/images/cancers-14-01580-g001.png)
Cancers | Free Full-Text | Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
![Cancers | Free Full-Text | Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice Cancers | Free Full-Text | Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice](https://www.mdpi.com/cancers/cancers-14-02718/article_deploy/html/images/cancers-14-02718-g001.png)
Cancers | Free Full-Text | Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice
![Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00868-x/MediaObjects/41392_2021_868_Fig1_HTML.png)
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy
![Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies - Huck - 2018 - Angewandte Chemie International Edition - Wiley Online Library Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies - Huck - 2018 - Angewandte Chemie International Edition - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3bdb0a2d-c53e-40d9-b159-8bd0237e0783/anie201707816-toc-0001-m.jpg)
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies - Huck - 2018 - Angewandte Chemie International Edition - Wiley Online Library
![IJMS | Free Full-Text | Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements IJMS | Free Full-Text | Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements](https://www.mdpi.com/ijms/ijms-22-00130/article_deploy/html/images/ijms-22-00130-g001.png)
IJMS | Free Full-Text | Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
![Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges | Science Advances Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges | Science Advances](https://www.science.org/cms/10.1126/sciadv.abi8618/asset/ac4025eb-4271-44cd-bb91-fb58f985531d/assets/images/large/sciadv.abi8618-f1.jpg)
Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges | Science Advances
![Frontiers | Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients Frontiers | Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients](https://www.frontiersin.org/files/Articles/914890/fimmu-13-914890-HTML/image_m/fimmu-13-914890-g001.jpg)
Frontiers | Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
![Biomedicines | Free Full-Text | Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions Biomedicines | Free Full-Text | Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions](https://www.mdpi.com/biomedicines/biomedicines-10-00821/article_deploy/html/images/biomedicines-10-00821-g001.png)